Work

The efficacy and safety of interval and post-reTURBT intravesical therapy for bladder cancer

Year: 2025

Type: article

Abstract: < 0.001). The greatest benefit appeared in high-grade, cT1 lesions. Our findings endorse IIT + PIT-particularly with BCG-as an effective strategy to reduce recurrence in high-risk bladder cancer.

Source: iScience

DOI: 10.1016/j.isci.2025.114152

Authors: Dongshan Chen, Zhen Li, Yapeng Sui, Yuan Zeng, Haochen Cui, Laiyuan Qiu, Lin Yang, Shuolei Li, Ziwei Wei, Siling Chen, Cong Zhang, Lei Yan

Institutions: Qilu Hospital of Shandong University, Capital Medical University, Beijing Chao-Yang Hospital, Capital Medical University, Affiliated Hospital of Xuzhou Medical College, Shandong Academy of Pharmaceutical Sciences, Shanghai Jiao Tong University, Shanghai Ninth People's Hospital, Shandong First Medical University

Language: English

Topic: Bladder and Urothelial Cancer Treatments

Subfield: Surgery

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: gold

Estimated APC paid: $3,240

Funders: Shandong University, Natural Science Foundation of Shandong Province

Awards: G5038981287, G6435517490, G7371358412

OpenAlex ID: W4416426272

FWCI:

Cites: 23

Cited by:

Related to: